Skip to main content
Equibles
LUCD logo

LUCD · Lucid Diagnostics Inc.

Track LUCD — free

Use LUCD with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.94 -0.01 (-1.23%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the accompanying unaudited condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 12, 2026
Market Cap
$190.95M
Shares
203.24M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.94 Open$0.94 Day$0.93–0.96 52W close$0.87–1.47 Avg vol 30d927K Short int12.8M · 6.3% float · 12.3d Short vol68% Last earningsAug 13, 2026 DataOct 2021–Sep 2026 Filing10-Q · Aug 12

Up next

Next earnings call
Nov 12, 2026 Est · unconfirmed · in 10 wks
Latest filing: 10-Q
filed Aug 12, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$5.45M
Trailing 12 months
Net income (TTM)
−$52.26M
Trailing 12 months
Revenue growth YoY
+26.7%
Year over year
Operating margin
-930.8%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+114.7%
Year over year · more shares
Price change (1Y)
-31.9%
Trailing year
Short interest
6.3%
Latest settlement · 12.3 days to cover
View all 114 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −16%
below
Price vs 50-day avg −4%
below
RSI (14) 44
neutral
MACD trend Negative
52-week position 11%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Very Weak
1-month return −3%
trailing
6-month return −33%
trailing
YTD return −14%
this year
Relative strength −48%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Accumulating
+14% holders QoQ · +26 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
6.31% of float · ▲ +5.8% MoM · 12.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
117 holders — near 3-yr high, broad support
Squeeze score 59
elevated · 0–100
Fundamentals
Fair
Revenue growth +79%
Y/Y
Gross margin 9%
contracting
EPS growth +17%
Y/Y
Free cash flow $-46.7M
Quant / Vol
risk profile
Very High
Volatility 64%
annualized · 1-yr
Max drawdown −41%
past year
ATR 5.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−16% Bearish
Price vs 50-day avg
−4% Neutral
RSI (14)
44 Neutral
MACD trend
Negative Bearish
52-week position
11% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Accumulating
+14% holders QoQ · +26 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
6.31% of float · ▲ +5.8% MoM · 12.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
117 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1 Now $1 · 11% Range high $1
vs 200-day avg -16% vs 50-day avg -4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
LUCD
Lucid Diagnostics Inc.
this stock
$190.95M -13.8% +79.0% — 6.3%
ABT
Abbott Laboratories
 $188.69B -13.5% +5.7% 30.3 1.2%
MDT
Medtronic plc
 $120.46B -2.0% +8.4% 23.2 1.1%
SYK
Stryker Corp
 $116.27B -13.8% +11.2% 31.4 1.8%
BSX
Boston Scientific Corp
 $69.27B -49.9% +12.5% 19.4 1.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
117
% held
30.3%
Net QoQ
+25.9M sh
Top holder
Alyeska Investment Group,…
Held Float
View
Held by Funds
Fund positions
72
View
Short & Settlement
Short Interest Rising
Shares short
12.8M
Days to cover
12.3d
Change
+700.1K sh
View
Short Volume
Short vol %
68%
As of
Sep 4, 2026
Short Total
View
Fails to Deliver
FTD shares
10
Value
$10
As of
Aug 13, 2026
View
Off-Exchange
Off-exchange %
63.1%
Week of
Jul 27, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$4.3M
Net income (FY)
$-58.0M
EPS diluted
$-1.05
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 13, 2026
This year
12
View
Proposed Sales
Value
$49.1K
Shares
33.9K
Filed
Sep 26, 2023
View
Exempt Offerings
Offering
$22.0M
Filed
Dec 6, 2024
View
Earnings & Events
Earnings Calls
Last call
Aug 13, 2026
View

Performance

5D 20D 120D MTD YTD
LUCD -5.2% -2.8% -32.9% -4.0% -13.8%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY -5.4% -2.4% -48.0% -4.4% -26.8%
Key facts CIK 1799011 CUSIP 54948X109 13F (30d) 78 filings 78 filers Visit website Investor relations